Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.

The effects of the protein kinase C (PKC) activators, phorbol ester 12-O-tetradecanoyl-13-phorbol acetate (TPA) and the marine natural product, bryostatin 1, on the growth and morphology of human breast cancer cell lines were examined. TPA (1 to 100 nM) inhibited growth of four of six cell lines by up to 75% in 5-day cultures. Bryostatin 1 inhibited growth of only MCF-7 cells and only at a high dose (100 nM). However, bryostatin 1 completely antagonized the growth inhibition and morphological changes induced by TPA in MCF-7 cells. The divergent effects of these two agents are associated with differing effects on PKC activity and isoform expression in MCF-7 cells. TPA induced rapid translocation of the PKC-alpha isozyme and PKC activity to the membrane fraction of MCF-7 cells. In contrast, bryostatin 1 treatment resulted in the loss of the PKC-alpha isozyme and PKC activity from both cytosolic and membrane compartments within 10 min of treatment. In coincubation assays the bryostatin 1 effect was dominant over that of TPA. Similar effects on PKC-alpha isozyme and PKC activity were seen in a second cell line whose growth was inhibited by TPA but not by bryostatin 1, MDA-MB-468. In contrast, in the T47D cell line, where TPA was not growth inhibitory, TPA failed to induce translocation of PKC-alpha to the cell membrane. Bryostatin, however, still caused loss of PKC-alpha isozyme and PKC activity from cytosolic and membrane fractions. Thus, differential actions of bryostatin 1 and TPA on PKC activity and alpha-isoform level in the membrane-associated fraction of MCF-7 and MDA-MB-468 cells may account for the divergent effects of these two agents on cell growth and morphology. These results suggest that the PKC-alpha isoform may specifically play a role in inhibiting growth of human breast cancer cells.

[1]  B. A. Hocevar,et al.  Selective translocation of beta II-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells. , 1991, The Journal of biological chemistry.

[2]  G. Schwartz,et al.  Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporine. , 1990, Journal of the National Cancer Institute.

[3]  S. Singletary,et al.  Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. , 1989, Cancer research.

[4]  Y Nishizuka,et al.  Alfred P. Sloan Jr. prize. Studies and prospectives of the protein kinase C family for cellular regulation , 1989, Cancer.

[5]  Y. Nishizuka.  The Albert Lasker Medical Awards. The family of protein kinase C for signal transduction. , 1989, JAMA.

[6]  P. Blumberg,et al.  Mimicry of bryostatin 1 induced phosphorylation patterns in HL-60 cells by high-phorbol ester concentrations. , 1988, Cancer research.

[7]  M. Dell'aquila,et al.  Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells. , 1988, Cancer research.

[8]  M. Hagiwara,et al.  Cell type-specific expression of protein kinase C isozymes in the rabbit cerebellum. , 1988, The Journal of biological chemistry.

[9]  F. Marks,et al.  Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro. , 1988, Carcinogenesis.

[10]  S. Barsky,et al.  Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Kraft,et al.  Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Dell'aquila,et al.  Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells. , 1987, Cancer research.

[13]  A. Kraft,et al.  Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60). , 1987, Oncogene.

[14]  W. Young,et al.  Distinct patterns of expression of different protein kinase C mRNAs in rat tissues , 1987, Cell.

[15]  F. Bayard,et al.  Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events. , 1987, Cancer research.

[16]  F. Huang,et al.  Isozymic forms of rat brain Ca2+-activated and phospholipid-dependent protein kinase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Darbon,et al.  Phorbol esters inhibit the proliferation of MCF-7 cells. Possible implication of protein kinase C. , 1986, Biochemical pharmacology.

[18]  A. Kraft,et al.  Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Kraft,et al.  Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor. , 1985, Biochemical and biophysical research communications.

[20]  L. Bachrach,et al.  Phorbol esters stimulate growth and inhibit differentiation in cultured thyroid cells. , 1985, Endocrinology.

[21]  J. Proietto,et al.  Tumour-promoting phorbol esters increase basal and inhibit insulin-stimulated lipogenesis in rat adipocytes without decreasing insulin binding. , 1985, Biochemical Journal.

[22]  L. Cantley,et al.  Phorbol esters induce differentiation in a pre-B-lymphocyte cell line by enhancing Na+/H+ exchange. , 1984, The Journal of biological chemistry.

[23]  T. Rink,et al.  Diacylglycerol and phorbol ester stimulate secretion without raising cytoplasmic free calcium in human platelets , 1983, Nature.

[24]  M. James,et al.  Characterization of a specific phorbol ester aporeceptor in mouse brain cytosol. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Y. Nishizuka,et al.  Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation. , 1982, Cell calcium.

[26]  Y Nishizuka,et al.  Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. , 1982, The Journal of biological chemistry.

[27]  J. F. Day,et al.  Antineoplastic Components of Marine Animals , 1970, Nature.